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ABSTRACT 
Oct4 is a protein that is involved in the retention of pluripotency in adipose derived stem cells 
(ADSCs). Despite this knowledge, Oct4’s exact role in the complex system used in maintaining 
pluripotency is not known. One approach to explore Oct4’s role would be through the use of 
cellular assays to control the expression of Oct4. This can possibly be accomplished by introducing a 
biological switch and the gene of interest into ADSCs. In this project, the GeneSwitch™ System is 
used to ultimately induce Oct4 expression. Before the GeneSwitch™ System can be used, the Oct4 
gene is extracted from murine embryonic stem cell (ES) RNA. This ES RNA is then used as a 
template to create complimentary DNA (cDNA) that can then be used to create an insert with the 
Oct4 gene. In addition to the cDNA, recognition sites for endonucleases must be added on to fully 
create the Oct4 insert. This insert could then be placed into one of the GeneSwitch™ System 
plasmids that have the same recognition sites and placed into ADSCs along with the plasmid that 
will act as a biological switch. With this system put into ADSCs, it is expected that Oct4 levels will 
be successfully controlled. Once controlled, Oct4 expression can be tested and investigations can be 
completed to determine how Oct4 expression levels influence pluripotency of ADSCs. This may 
have significant impact on the creation of regenerative medicine.  
 
INTRODUCTION 
Cells are the most basic living 
component that make up an organism. They 
divide, communicate, metabolize, transport, and 
complete many other tasks that the human body 
requires in order to remain at homeostasis. 
Remarkably, cells grouped together as tissues, 
organs and organ systems can accomplish much 
more complex regulatory processes than 
individual cells. Since cells have such an 
important role in the body, losing large amounts 
of cells would make normal body functions 
more difficult. The body is often able to replace 
naturally lost cells, but may not be able to 
replace large amounts of cells lost due to injury 
or disease—at least not quickly. Regenerative 
medicine has made major scientific progress in 
procedures and tissue repair that can help the 
body to replace cells on a larger scale. For 
example, people who have been severely burned 
can replace the lost tissue through the use of 
regenerative medicine. Stem cells, immature 
cells that have not differentiated (i.e. specialized 
into a specific type of cell), have many 
possibilities in terms of what kind of cell they 
can become; this ability or potential to become 
any type of cell is referred to as pluripotency. 
This characteristic makes them an important 
resource in the field of regenerative medicine 
and holds tremendous potential for the future 
of all medicine (Pan et al. 2002). There are quite 
a few sources from which stem cells can be 
attained, but the most commonly discussed 
origins of stem cells are bone marrow or 
embryos.  
Despite the potential and major 
progress in the study of stem cells, there are still 
some ethical and procedural issues that come 
with stem cell retrieval. For example, the use of 
embryonic stem cells presents a serious dilemma 
for many U.S. citizens. Others raise concern 
about the procedure to gather bone marrow 
stem cells (BMSCs), a process that is relatively 
expensive, intrusive, and has a comparatively 
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low yield (Zhu et al. 2008). Adipose derived 
stem cells (ADSCs) have become an attractive 
alternative source; these cells are cheaper, easier 
to obtain, and can be harvested in a much less 
invasive manner. This can be attributed to the 
abundance of fat available for medicinal use 
from either the patient or willing donors (Zhu et 
al. 2008). Not only is the use of ADSCs cheaper 
and more efficient, it is also still capable of 
having specified differentiation induced. This 
can be seen through an experiment conducted 
by Zhu et. al (2008), where ADSCs were 
successfully induced to differentiate into fat 
cells, bone cells, cartilage cells, and heart muscle 
cells.  
While stem cells are able to 
differentiate, inducing their differentiation into 
specific cells can be more difficult. Typically, 
epigenetics—the study of how signals from an 
environmental or external source affect genes—
plays a large role in the differentiation of stem 
cells. Cells can respond to signals in different 
ways based on many factors including: what 
kind of signal is being sent, how strong the 
signal is, and where the signal originates 
(Weidgang et al. 2016). Certain signals are able 
to trigger the stem cells to specifically 
differentiate into a certain type of cell. Using 
this same notion, it is possible for scientists to 
create induced pluripotent stem cells (iPSCs) 
that allow stem cell differentiation to be 
controlled through many methods including the 
use of a signal that can be operated using a 
biological “switch” (Stadtfeld and Hochedlinger 
2010).  This “switch,” depending on what genes 
it controls and what kinds of signals that gene is 
in control of, would be used to control whether 
the signal is “on” or “off” and the intensity of 
the signal. In order to make use of a “switch” to 
control stem cell differentiation, the gene of 
interest would have to be a gene that plays a 
role in the differentiation of stem cells. One 
such gene could be Oct4, a transcription factor 
that plays an important role in retaining the 
pluripotency of stem cells (Kim et al. 2009). 
Oct4 is usually used alongside many other 
transcription factors such as Sox2, Nanog, Klf4, 
and c-Myc in order to regulate the differentiation 
and retention of pluripotency of a stem cell 
(Takahashi and Yamanaka 2006). Typically, 
many transcription factors are needed to control 
pluripotency of stem cells as noted by the 
research of Boyer et al. (2005) with embryonic 
stem cells that are involved in the early stages of 
embryo development. Out of the transcription 
factors listed, Oct4 is the only one that is 
absolutely essential for self-renewal and 
pluripotency of a stem cell (Jerabek et al. 2014); 
this means that there is a chance that controlling 
the pluripotency of stem cells could possibly be 
done by Oct4 only.  
The work described here focused on 
controlling Oct4 expression through the use of 
Invitrogen’s GeneSwitch™ System. An insert 
with Oct4 and two recognition sites had to be 
made and introduced to the pGene vector of 
the GeneSwitch System—which should have 
the same recognition sites—through the use of 
cloning. From there, further investigation can 
be done to study whether the expression of 
Oct4 alone can regulate the pluripotency of 
murine ADSCs. Once more studies have been 
completed using murine ADSCs, it will be 
possible to expect many of the same findings 
within human ADSCs due to the fact that the 
Pou5f1 gene sequence that controls expression 
of Oct4 for humans is 87% identical to that of 
murine Pou5f1 (Jerabek et al. 2014). 
 
METHODS 
Embryonic stem cell ribonucleic acid 
(ES RNA) was used as a template to create 
complementary deoxyribonucleic acid (cDNA) 
through the process of reverse transcription. 
Reverse transcription is the formation of cDNA 
using RNA as a template rather than the 
formation of RNA from DNA that is seen with 
normal transcription. An iScript™ Reverse 
Transcription Supermix for quantitative reverse 
transcription polymerase chain reaction (RT-
qPCR) from Bio-Rad and thermocycler were 
used to create the cDNA. The reaction protocol 
used to create the cDNA was 5 minutes of 
priming at 25°C, 30 minutes of reverse 
transcription at 42°C, and 5 minutes of reverse 
transcriptase inactivation at 85°C. The cDNA 
acted as a template for the polymerase chain 
reaction (PCR) process used to amplify the 
Oct4 gene for molecular cloning. The cDNA, 
which already contained the Oct4 gene, was 
 
41 
reacted with oligonucleotide primers from 
Eurofins Genomics containing recognition sites 
for KpnI and NotI in order to make the Oct4 
insert. The 5’ primer (5-
CTTGGTACCATGGCTGGACACCTGGCT 
TCAGACTTCGCC) contained the recognition 
site for KpnI and the 3’ primer (5-CGAG 
CGGCCGCCCCCGTTTGAATGCATGGGA
GAGCCCAGAGCAGTG) contained the 
recognition site for NotI. A 3’ primer with a 
stop codon and the recognition site for NotI (5-
CGAGCGGCCGCCCCCTCAGTTTGAATG
CATGGGAGAGCCCAGAGCAGTG) was 
also used during PCR. The reaction protocol 
used for PCR was 2 minutes of denaturing at 
94°C, 30 seconds of denaturing at 94°C, 30 
seconds of annealing at 50°C, 3 minutes of 
elongation at 72°C, 1 minute of elongation at 
72°C, and storage of PCR reaction at 4°C until 
the PCR reaction is retrieved. The PCR reaction 
went through 41 cycles of 30 second-
denaturing, 30 second-annealing, and 3 minute-
elongation before moving on to the step of 1 
minute-elongation. Gel electrophoresis was 
completed and the gel was viewed through a 
Gel Doc™ XR+ System to ensure that the 
insert was the size it was expected to be. The 
insert was removed from the gel and gel DNA 
extraction was completed to purify the insert. 
The insert and pGene vectors—from 
Invitrogen’s GeneSwitch™ System—were then 
digested in KpnI and NotI endonucleases at 
37°C in a thermocycler to create the correct cuts 
on both the insert and vector. The DNA of the 
insert and vector was purified using gel 
electrophoresis. Each sample was loaded on to a 
1% agarose gel and separated for 30 minutes at 
115V. The agarose gel containing the samples 
was viewed under a Gel Doc™ XR+ System 
from Bio-Rad using ethidium bromide to 
invoke DNA fluorescence. The DNA was 
carefully extracted from the gel and further 
purified using the Gel DNA Extraction 
protocol. 
 
RESULTS & DISCUSSION 
ES RNA went through reverse 
transcription to create cDNA with the desired 
Oct4 gene. The presence of Oct4 in the cDNA 
was confirmed by running a gel electrophoresis 
on a PCR reaction that incorporated cDNA and 
Oct4 primers that could be used to identify 
Oct4 using only a small segment of the Oct4 
gene. It was expected that a band around 0.1kB 
would appear in the agarose gel and a band was 
present in the expected location as seen in 
Figure 1. 
 
 
Figure 1. Gel Electrophoresis results for the PCR 
reaction including cDNA as the template and primers 
to identify a short sequence of Oct4. The lowest lane 
with bands contains the base pair ladder. The middle 
lane with bands contained the PCR product for the 
reaction using Oct4 primers and 0.5µL of cDNA. The 
top lane with bands contained the PCR product for the 
reaction using Oct4 primers and 2µL of cDNA. The 
expected band size for this PCR reaction was 100 base 
pairs or 0.1kB. 
 
Once the cDNA was made, a PCR was 
completed using a 5’ primer and 3’ primer to 
add on recognition sites to the cDNA, but the 
PCR product did not appear in the region it was 
expected to be when it was viewed after running 
a gel electrophoresis. It was expected to appear 
around the 1kB region, but the band was found 
well below the 0.5kB region as seen in Figure 2. 
PCR reactions using various concentrations of 
MgCl2 and DMSO were completed, but neither 
reaction resulted in bands within the 1kB 
region, as seen in Figure 3 and Figure 4; all 
reactions resulted in bands well below the 0.5kB 
region. A PCR reaction incorporating one of the 
Oct4 primers used to confirm the successful 
creation of cDNA and the 5’ primer was 
completed along with a PCR reaction with the 
other Oct4 primer and the 3’ primer. The 
resulting gel, shown in Figure 5, indicates that 
the reaction with the 3’ primer worked, but the 
reaction with the 5’ primer did not. 
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Figure 2. Gel Electrophoresis results for the PCR 
reaction including cDNA as the template, 5' primer 
with a recognition site for KpnI, and 3’ primer with 
recognition site for NotI. The lowest lane with bands 
contains the base pair ladder. The second lowest lane 
contains the control PCR reaction using WT NUR, T7 
promoter primer, and T7 terminator primer. The 
middle lane contains the PCR product for the reaction 
with cDNA as the template, a 5’ primer with a KpnI 
recognition site, and a 3’ primer with a NotI 
recognition site. The second highest lane with bands 
contains the PCR product for the reaction with cDNA 
as the template, a 5’ primer with a KpnI recognition 
site, and a 3’ primer with a NotI recognition site and a 
stop codon. The highest lane with bands contains the 
PCR product for the reaction with cDNA as the 
template, a 5’ primer with a NdeI recognition site, and 
a 3’ primer with a BamHI recognition site. The 
expected band size for the PCR reactions (excluding 
the control) were 1000 base pairs or 1kB.  
 
 
Figure 3. Gel electrophoresis results for PCR reactions 
with varying MgCl2 concentrations. Each PCR reaction 
made use of cDNA as the template, a 5’ primer with a 
KpnI recognition site, a 3’ primer with a NdeI 
recognition site, and a specific concentration of MgCl2. 
The MgCl2 concentrations ranged from 0mM to 4mM 
and increased in increments of 0.5mM.  
 
There are two possible reasons why the 
PCR of the 5’ primer failed. One reason is that 
the 5’ primer was not made correctly. Since the 
primer was designed while looking specifically at 
the expected cDNA sequence, there is very little 
reason to believe that primer design is the cause 
for this PCR to fail. The other possible reason is 
that the reverse transcription of ES RNA to 
make the cDNA did not completely work. 
When reverse transcription happens, the primer 
used during the process will find the template’s 
poly-A tail in order to anneal to the 3’ end of 
the mRNA. Once annealed, the primer will be 
used to copy the mRNA to cDNA, but it may 
not copy the entire template. This means that 
some of the 5’ end of the cDNA is ultimately 
missing. Without this 5’ end, the designed 5’ 
primer will not have an overlapping template 
sequence to bind to and will not be able to 
amplify the cDNA.  
A PCR to figure out where the 5’ end of 
the cDNA started was completed. Primers that 
started at various intervals of the 5’ end of the 
cDNA were made before being used in separate 
PCR reactions. Each reaction also used the 3’ 
primer. A gel electrophoresis was completed 
after the PCR and bands were seen just below 
the desired region of 1kB, as seen in Figure 6. 
The bands were also sequentially increasing—
which is what was expected—because of the 
fact that each primer was closer to the 5’ end of 
the cDNA than the last. With this PCR, it was 
now known that the cDNA was completed at 
least to the 50th nucleotide of the expected 
cDNA sequence. It was decided that another 
PCR would be completed to manually build on 
the first 49 nucleotides. This PCR was 
completed using two primers that would build 
onto one another to form the remaining 
nucleotides needed for the cDNA. A gel 
electrophoresis was completed to see if the 
appropriate bands could be found after each 
build was added on to the cDNA and 3’ primer. 
Bands around the 1kB marker were expected 
and found after viewing the agarose gel as seen 
in Figure 7. 
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Figure 4. Gel electrophoresis results for PCR reactions 
with varying DMSO percentages. Each PCR reaction 
made use of cDNA as the template, a 5’ primer with a 
KpnI recognition site, a 3’ primer with a NdeI 
recognition site, and a specific concentration of 
DMSO. The DMSO percentages ranged from zero 
percent (0µL) to 3 percent (1.5µL). 
 
 
Figure 5. Gel electrophoresis results for PCR reactions 
using cDNA as the template, one of the Oct4 
identifying primers, and either the 5' primer or 3' 
primer. The lowest lane with bands contained the base 
pair ladder. The second lowest lane with bands 
contained the PCR product for cDNA and the Oct4 
identifying primers. The third lowest lane with bands 
contained the PCR product for the cDNA, 5’ primer 
with a KpnI recognition site, and one of the Oct4 
identifying primers. The third highest lane with bands 
contained the PCR product for cDNA, 3’ primer with a 
NotI recognition site, and one of the Oct4 identifying 
primers. The second highest lane with bands contained 
the PCR product for cDNA, 5’ primer with NdeI, and 
one of the Oct4 identifying primers. The highest lane 
with bands contained the PCR product for cDNA, 3’ 
primer with BamHI, and one of the Oct4 identifying 
primers. 
 
Figure 6. Gel electrophoresis results for PCR reactions 
with cDNA as the template, a 3' primer with a NotI 
recognition site, and of the primers starting at various 
intervals on the 5' end of the cDNA. 
 
 
Figure 7. Gel electrophoresis results for PCR reactions 
with cDNA as the template, a 3' primer with a NotI 
recognition site, and either one or both of the Build 
primers. 
 
After the cDNA received the needed 
recognition site from the 5’ primer, the newly 
made Oct4 insert just needed to be cloned into 
the pGene plasmid before the pGene and 
pSwitch plasmids could then be transfected into 
the murine ADSCs and Oct4 expression levels 
could be investigated.  
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